Humana, Cigna, BCBS, Molina file amended US antitrust claims in case over Revlimid
MLex Summary: Humana, Cigna, Blue Cross Blue Shield, and Molina Healthcare filed an amended US antitrust complaint accusing Celgene of illegally closing off generic competition to branded Revlimid. See attached file. ...To view the full article, register now.
Already a subscriber? Click here to view full article